MedPath

Transorbital and transtemporal ultrasound to predict EVD weaning failure in patients with increased intracranial pressure - a prospective, multicenter study

Conditions
G91.9
Hydrocephalus, unspecified
Registration Number
DRKS00033089
Lead Sponsor
niversitätsmedizin Göttingen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
190
Inclusion Criteria

Planned EVD weaning trial
Acute subarachnoid hemorrhage (SAH) or
Acute intracerebral hemorrhage with ventricular collapse or
Meningitis/encephalitis or
Acute cerebral edema or
Severe TBI (typically GCS 3-8)

Exclusion Criteria

Age < 18 years
Decompressive hemicraniectomy
Acute injuries to one and/or both eyes in which further damage cannot be reliably ruled out by the ONSD measurement (even with compliant device settings).
Z.n. Operations in the area of the orbit or N. II, which could influence the measurement result
Chronic inflammatory changes in the II nerve (e.g. multiple sclerosis)
Chronic ICP elevation (e.g. pseudotumor cerebri)
Chronic hydrocephalus syndromes
Chronic CSF hypotension syndromes

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EVD-Weaning failure
Secondary Outcome Measures
NameTimeMethod
Optic nerve sheath diameter (ONSD) after 24 hours, change in ONSD from initial measurement and after 24 hours, CT/MR imaging: width of the 3rd ventricle; Evan’s index, parieto-occipital ratio (POR) and temporal ratio (TR)
© Copyright 2025. All Rights Reserved by MedPath